Scientists urge early detection, Africa-based trials for prostate cancer

Health experts have renewed calls for early detection and Africa-based clinical trials to address the burden of prostate cancer among men of African descent. The appeal came in Lagos during the 20th anniversary of the Prostate Cancer Transatlantic Consortium (CAPTC), a network of researchers, clinicians, and survivors. Prof. Folakemi Odedina of the Mayo Clinic described […]

Health experts have renewed calls for early detection and Africa-based clinical trials to address the burden of prostate cancer among men of African descent.

The appeal came in Lagos during the 20th anniversary of the Prostate Cancer Transatlantic Consortium (CAPTC), a network of researchers, clinicians, and survivors.

Prof. Folakemi Odedina of the Mayo Clinic described prostate cancer as a “silent killer” that devastates families when detected late.

“African men are still more likely to be diagnosed at a late stage and more likely to die from prostate cancer than their counterparts in Europe or North America. That is why we cannot relent,” she said.

She added that awareness and tailored treatment remain critical: “If a man is diagnosed early, he can be cured. But treatments designed for the West do not always fit Africa. We must adapt strategies to our realities.”

Dr. Ebenezer Nkom, a consultant surgeon, stressed that the disease often leaves families broken. “When the man goes, the family scatters. But if you get it early, the chances of cure are real,” he said.

Prof. Solomon Rotimi of Covenant University called for more Africa-based drug trials. “You cannot enter your house through another man’s gate. Our men need treatments tested here, not borrowed results from elsewhere,” he noted.

A survivor, retired Captain Yahaya Ayinde Yahaya, said he has turned his diagnosis into advocacy. “I organised free tests for over 300 people in my community. That is how we break the stigma and save lives,” he said.

CAPTC leaders said the consortium will continue to groom young African scientists and push for policies that expand screening, research, and survivor support.